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ERK phosphorylation and miR-181a expression
modulate activation of human memory TH17 cells
Federico Mele1, Camilla Basso1, Cristina Leoni1, Dominik Aschenbrenner1, Simone Becattini1,2,
Daniela Latorre1, Antonio Lanzavecchia1,2, Federica Sallusto1,* & Silvia Monticelli1,*
T helper (TH) cell polarization during priming is modulated by a number of signals, but
whether polarization to a given phenotype also inﬂuences recall responses of memory TH
cells is relatively unknown. Here we show that miR-181a is selectively induced in both human
and mouse naive T cells differentiating into the TH17, but not TH1 or TH2 subset. In human
memory TH17 cells, miR-181a regulates responses to cognate antigens through modulation of
ERK phosphorylation. By enhancing the signalling cascade from the T-cell receptor, such
molecular network reduces the threshold of TH17 cell activation. Moreover, at a late time
point, the same network induces a self-regulatory mechanism dependent on ID3, a negative
regulator of transcription factors that control RORC expression, thus modulating TH17 activity.
Our results demonstrate that the phenotype acquired by TH cells during priming contributes
to their threshold of activation to secondary antigenic stimulations, thus inﬂuencing memory
responses.
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F
ollowing antigenic stimulation, naive CD4 T cells proliferate
and differentiate to a number of different memory and
effector subsets, with responses tailored to the type of
pathogen encountered, and able to migrate to speciﬁc tissues to
eradicate infection. TH17 cells are characterized by the ability to
produce the proinﬂammatory cytokine IL-17, and are involved in
epithelial and neutrophil-mediated immune responses against
extracellular pathogens, especially bacteria and fungi. IL-17
induces the production of a broad range of proinﬂammatory
cytokines and chemokines by a variety of cells1, and its expression
must be carefully regulated. Indeed, despite their clear protective
functions, TH17 cells are also known to have prominent roles in
the pathogenesis of autoimmune diseases such as rheumatoid
arthritis and multiple sclerosis2.
The differentiation of naive T cells into cytokine-producing
effector T-cell subsets is inﬂuenced by a variety of factors,
including the cytokine milieu and the presence of adequate co-
stimulation, but also the afﬁnity of the T-cell receptor (TCR) for
the antigen, the duration of antigen stimulation, as well as the
antigen concentration during priming3–5. For example, it is well
established that mouse IL-4-producing TH2 cells are preferentially
generated by priming with a weak signal through the TCR while
TH1 cells are generated by priming with a strong signal4,6. More
recently, low TCR strength was shown to promote IL-17
production by human CD4 T cells7. Among the factors
implicated in the control of T-cell responses and TCR threshold
of activation are microRNAs (miRNAs). MiRNAs are small
noncoding RNA molecules with diverse and established roles in
regulating differentiation, proliferation and function of most
immune and non-immune cells investigated so far8,9. They also
have critical roles in immune responses through their ability to
modulate T-cell activation, proliferation and effector functions9.
Two miRNAs were reported to be involved in the regulation of
TCR activation: miR-146a and miR-181a (refs 9–13). MiR-146a
regulates the intensity of NF-kB activation upon TCR stimulation.
T cells lacking miR-146a are hyperreactive in both acute and
chronic antigenic responses and give rise to defective memory
responses13. MiR-181a is highly expressed in thymocytes14, and its
dysregulated expression impairs both positive and negative thymic
selection11. The effects of miR-181a during priming of naive T
cells are mediated by the downregulation of a number of
phosphatases, leading to increased levels of phosphorylated
signalling intermediates, such as the extracellular signal-
regulated kinases (ERK), and to an overall reduction of the TCR
signalling threshold11. MiR-181a expression therefore increases
responses to otherwise weak agonists and even antagonists, and is
itself modulated by TCR signals15. Since all previous studies were
focused on thymocyte development and priming of naive T cells, a
role for miR-181a during a secondary T-cell response remains to
be explored.
Although most studies insofar were focused on the relationship
between the properties of the input signals and their impact on
polarization, the reciprocal interdependence between polarization
and antigen responses is largely underexplored. Here, we show
that human memory TH17 cells differ from memory TH1 and
TH2 cells because of their sustained ERK phosphorylation after
the initial TCR triggering. Such sustained signalling depended on
a feed-forward, self-maintaining loop involving miR-181a, which
favoured the maintenance of ERK phosphorylation through the
downmodulation of phosphatases. In turn, sustained ERK
phosphorylation maintained high levels of miR-181a expression.
This mechanism appeared to be predominant in TH17 cells
compared with other subsets, and enabled TH17 cells to respond
to anti-CD3 crosslinking or to speciﬁc antigens with a lower
threshold of activation compared with TH1 and TH2 cells.
Consistently, during priming of naive T cells, miR-181a was
speciﬁcally induced by cytokines that favoured TH17 but not TH1
or TH2 polarization. By inducing ID3, a negative regulator of
transcription that acts by preventing binding of bHLH transcrip-
tion factors to DNA, sustained ERK phosphorylation also
regulated the expression of RORC and IL17 in recently activated
TH17 cells, thus limiting in a cell-intrinsic manner the potential
negative consequences of TH17-cell activation.
Sustained ERK phosphorylation is therefore a characteristic
feature of human memory TH17 cells, which determines on one
hand the threshold of activation to a subsequent encounter with
an antigen and on the other hand it provides a built-in
mechanism to dampen cytokine production after the initial
response has occurred, thereby limiting potential tissue damage.
Most importantly, our data provide the mechanistic bases for the
observation that, given the same TCR speciﬁcity, the magnitude
of a secondary response is also determined by the phenotype
acquired during initial priming and polarization.
Results
miR-181a is acquired by differentiating TH17 cells. To study
human memory T cells with a polarized TH1, TH2 and TH17
phenotype, we isolated CD4þ CD45RA T-cell subsets from the
blood of healthy donors on the basis of the expression of CCR6,
CXCR3 and CCR4, as previously described16. Memory TH17 cells
(CCR6þCCR4þ ) isolated ex vivo expressedB4-fold more miR-
181a compared with TH1 (CXCR3þCCR6 ) and TH2
(CCR4þCCR6 ; Fig. 1a), consistent with our previous ﬁndings
using miRNA proﬁling12. On TCR stimulation, memory TH17
cells further increased expression of miR-181a (Fig. 1b).
To ask whether the preferential expression of miR-181a was
imprinted at the time of priming, we sorted human naive CD4 T
cells and we activated them in vitro with anti-CD3 and anti-CD28
antibodies in the presence of polarizing cytokines. Addition of IL-
12 or IL-4 (for TH1 and TH2 differentiation, respectively) had no
effect on miR-181a expression, whereas miR-181a was induced by
signals that favour human TH17 cell differentiation17, namely IL-
6þ IL-1b (Fig. 1c, left panel). Interestingly, addition of the
individual cytokines (IL-6 or IL-1b) was also able to induce
moderate expression of miR-181a, suggesting that cytokine
signalling upon priming is sufﬁcient to induce miR-181a
expression in TH17-polarizing conditions. Human naive CD4 T
cells were also in vitro primed in the presence of Candida albicans
as described18. In these conditions, T cells acquired a mixed
phenotype (Supplementary Fig. 1), and a cytokine secretion assay
was therefore used to separate IL-17– (IFN-gþ or IL-4þ ) and IL-
17þ cells from the same culture. Consistent with the ﬁndings on
memory TH17 cells isolated directly from the peripheral blood,
also these in vitro-polarized IL-17-producing cells expressed
higher levels of miR-181a compared with the non-IL-17-
producing T cells (Fig. 1c, middle panel). Finally, addition of
TH17-polarizing cytokines (IL-6 and TGFb) alone or in
combination, to mouse naive T cells primed in vitro with
antibodies to CD3 and CD28 also induced higher levels of miR-
181a compared with the addition of IL-12 or IL-4, respectively
(Fig. 1c, right panel). Collectively, these data indicate that miR-
181a is acquired by both human and mouse naive T cells
differentiating towards the TH17 lineage, and uncover an
important role for cytokine signalling in its induction.
miR-181a contributes to sustained ERK phosphorylation. MiR-
181a was shown to be highly expressed in thymocytes and to
regulate the threshold of activation of these cells by modulating
TCR signalling through ERK phosphorylation11,14. We therefore
asked whether memory TH17 cells display differences in the
threshold of activation as compared with memory TH1 and TH2
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cells. TH-cell subsets were isolated ex vivo from peripheral blood
and stimulated with increasing concentrations of anti-CD3
antibody together with a ﬁxed amount of plate-bound anti-
CD28 antibody. Five days after stimulation, cell proliferation in
each subset was assessed by 3H-thymidine incorporation assay
(Fig. 2a). At low concentrations of anti-CD3, a proliferative
response was detectable only in memory TH17 cells, indicating
that this subset has the lowest threshold of activation. With
increasing concentrations, proliferation of TH17 cells was
comparable to that of memory TH1 cells, but remained superior
to that of memory TH2 cells, which responded only at relatively
high anti-CD3 concentrations. Consistently, EC50 values
calculated on seven independent donors were signiﬁcantly
lower in TH17 cells as compared with TH2 and TH1 cells (Fig. 2b).
The difference in the threshold of activation in particular
between TH17 and TH2 cells prompted us to investigate whether
miR-181a could modulate ERK phosphorylation induced by TCR
triggering in these cells. Memory TH17 and TH2 cells were
transfected with either a miR-181a mimic or a scrambled control
oligonucleotide and then stimulated with anti-CD3 and anti-
CD28 antibodies. ERK phosphorylation was assessed by intra-
cellular staining (Fig. 2c). Compared with TH2 cells, TH17 cells
showed moderately but consistently higher levels of ERK
phosphorylation after 1 h of stimulation (Fig. 2d). Overexpression
of miR-181a mimic allowed sustained ERK phosphorylation for a
longer period of time in both T-cell subsets (Fig. 2c,d), suggesting
that levels of ERK phosphorylation in memory T cells may be
regulated by miR-181a expression regardless of their phenotype.
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Figure 1 | miR-181a is highly expressed in TH17 cells. (a) Primary human memory TH1, TH2 and TH17 were sorted from peripheral blood of healthy donors
on the basis of the expression of chemokine receptors and immediately lysed in Trizol for RNA extraction. Expression of miR-181a was assessed by qRT–
PCR relative to RNU48, which was used as endogenous control. Shown are the compiled results from ﬁve independent donors (mean±s.d.). P values were
calculated by paired Student’s t-test, two-tailed. (b) Primary human cell subsets were sorted from peripheral blood as in a and immediately lysed in Trizol or
stimulated with plate-bound anti-CD3 (5mgml 1) and anti-CD28 (1 mgml 1) antibodies for 5 days before lysis in Trizol. MiR-181a expression was
assessed by qRT–PCR, using RNU48 as endogenous control. Shown are the compiled results from three independent donors (mean±s.d.). (c) (Left panel)
Human naive T cells were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies and cultured in the presence of the indicated cytokines for 12
days. Total RNA was then extracted and miR-181a expression measured by qRT–PCR. Shown are the compiled data for two donors (mean±s.e.m.). (Middle
panel) Human naive CD4 Tcells were sorted from the peripheral blood of healthy donors and labelled with CFSE, prior culture with autologous monocytes
pulsed with heat-inactivated C. albicans. The proliferating Tcells were expanded with IL-2, and CFSE-negative antigen-speciﬁc cells were analysed on day 17
for the production of IL-17, IL-4 and IFN-g by intracellular staining. T cells expressing the signature cytokines IFN-g, IL-4 and IL-17 were sorted by cytokine
secretion assay and lysed in Trizol before analysis of miR-181a expression. Data are representative of two independent experiments. (Right panel) Mouse
naive 2D2 cells were isolated from spleen and lymph nodes and were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies in the presence of
the indicated cytokines. Polarization was assessed by intracellular staining 5 days later and miR-181a expression was assessed by qRT–PCR; snoRNA202
was used as endogenous control. Shown are the compiled data for three mice (mean±s.e.m.), representative of ﬁve independent experiments.
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The ability of miR-181a to regulate ERK phosphorylation
implies that the higher endogenous levels of miR-181a observed
speciﬁcally in TH17 cells may lead to sustained ERK phosphor-
ylation compared with other T-cell subsets. We therefore isolated
TH17 and TH2 clones from memory T cells by limiting dilution.
Increased and sustained ERK phosphorylation was observed upon
stimulation of all analysed clones, although TH17 cells showed
consistently higher levels (Fig. 2e). Remarkably, TH17 clones
maintained ERK phosphorylation for a very prolonged period of
time (up to 5 days) after stimulation (Supplementary Fig. 2).
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Figure 2 | Increased ERK phosphorylation mediated by miR-181a. (a) Primary human memory TH1, TH2 and TH17 were sorted from peripheral blood and
immediately stimulated on plate-bound anti-CD28 (1mgml 1) with increasing concentrations of anti-CD3 antibody. Five days after stimulation, cell
proliferation was assessed by 3H-thymidine incorporation assay. One representative donor is shown. (b) Compiled EC50 values calculated for seven
independent donors analysed as in a (mean±s.d.). P values were calculated by paired Student’s t-test, two-tailed. (c) TH2 and TH17 cells were sorted from
peripheral blood and immediately transfected with a miR-181a mimic or a negative scrambled control oligonucleotide. Forty-eight hours after transfection,
cells were stimulated with anti-CD3 and anti-CD28 antibodies for the indicated times and phosphorylation of ERK was assessed by intracellular staining.
Shown are data from one representative donor. (d) Compiled results of multiple experiments as in c (n¼4 individual donors for TH2 and n¼6 individual
donors for TH17 (mean±s.d.). P values were calculated by paired (within each subset) or unpaired (across different T-cell subsets) Student’s t-test, two-
tailed. Shown are MFIs for pERK observed after 1 h of stimulation with anti-CD3 and anti-CD28 antibodies. (e) Human TH17 and TH2 clones were
stimulated with 1mgml 1 anti-CD28 and 5 mgml 1 of anti-CD3 antibodies. Levels of ERK phosphorylation were measured at the indicated times by
intracellular staining. Each line represents one clone. (f) TH17 cells were transfected as in c, and total RNA was extracted to assess expression of the
indicated phosphatases by qRT–PCR. 18S RNA was used as endogenous control. Data are representative of two independent experiments.
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The link between miR-181a expression and modulation of ERK
phosphorylation through the regulation of phosphatases is well
established in a number of experimental systems11,15,19–22. We
therefore analysed the expression of DUSP5 and DUSP6, two
ERK-speciﬁc phosphatases acting in the nucleus and cytoplasm,
respectively23, and also of the phosphatase PTPN11 (SHP-2),
which are all validated direct targets of miR-181a (ref. 11).
Consistent with previous work11, forced miR-181a expression in
ex vivo-isolated memory TH17 cells led to a reduction in the
mRNA levels of all of these phosphatases (Fig. 2f), indicating that
miR-181a expression in TH17 cells might lead to sustained ERK
phosphorylation through the downregulation of phosphatases
that negatively control TCR signalling.
miR-181a modulates antigen sensitivity in TH17 cells. We next
assessed whether miR-181a expression could modulate the pro-
liferative responses of TH17 cells to antigens presented by anti-
gen-presenting cells. Human memory TH17 cells were isolated
from peripheral blood, labelled with CFSE (5(6)-carboxy-
ﬂuorescein diacetate N-hydroxysuccinimidyl ester) and cultured
with C. albicans in the presence of autologous monocytes. In this
experimental system, T-cell proliferation depends on MHC-II
antigen presentation18,24. After expansion in IL-2, the speciﬁc
proliferating blast cells were ﬁrst transfected with a miR-181a
mimic, a scrambled control oligonucleotide or a blocking miR-
181a antagomir, and then restimulated with monocytes in the
presence of increasing concentrations of C. albicans antigens.
Forced expression of miR-181a led to a more robust proliferation
of memory TH17 cells in low stimulatory conditions (Fig. 3a).
Importantly, blocking miR-181a in TH17 cells using an antagomir
led to reduced activation and proliferation of these cells (Fig. 3a).
Similar results were obtained transfecting ex vivo freshly isolated
TH17 cells and then stimulating them with different numbers of
C. albicans particles (Fig. 3b). Similar results were also obtained
using a completely different antigen, the tetanus toxoid
(Supplementary Fig. 3). Collectively, these data indicate that
miR-181a expression regulates T-cell proliferation in response to
cognate antigenic stimulation.
Since in the above experiments we utilized memory TH17 cells
containing a pool of different TCR speciﬁcities, the possibility
remained that altered miR-181a expression was somehow
favoring the expansion of a few selected clones. To assess
whether increased miR-181a expression leads to a cell-intrinsic
decrease in the threshold of activation to a given antigen, we
selected individual TH17 clones speciﬁc for C. albicans. Each
clone (composed of cells carrying the same TCR speciﬁcity) was
then divided into aliquots and transfected with either a miR-181a
mimic, antagomir or a control oligonucleotide. As shown in
Fig. 3c for two exemplary T-cell clones, cells transfected with a
miR-181a mimic or antagomir showed increased or decreased
proliferation, respectively, in response to stimulation with
C. albicans, as compared with the same cells transfected with a
control oligonucleotide. These data indicate that, through the
regulation of ERK phosphorylation, miR-181a modulates antigen
sensitivity in TH17 cells in a cell-intrinsic manner.
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Increased sensitivity of antigen-speciﬁc TH17 cells. Our data
imply that if a given antigen is recognized by two memory T cells
with the same TCR speciﬁcity, their proliferative response will
also be dictated in a cell-intrinsic manner by the phenotype
acquired during the initial priming. Since also mouse TH17 cells
expressed higher levels of miR-181a compared with other T-cell
subsets (Fig. 1c), to address more speciﬁcally this possibility in an
in vivo system, we took advantage of TCR-transgenic murine
cells. MOG (myelin oligodendrocyte glycoprotein)-speciﬁc 2D2
cells25 were adoptively transferred into C57Bl/6 mice.
Immunization was then performed with MOG35–55 in the
presence of either complete Freund’s adjuvant (CFA), which
favoured differentiation mainly of IL-17-producing T cells, or
alum, which instead favoured polarization of IL-4-producing T
cells (Fig. 4a). Six days after immunization, polarized 2D2 cells
were recovered from the draining lymph nodes and restimulated
in vitro with dendritic cells pulsed with increasing concentration
of MOG35–55. Proliferation was assessed by a 3H-thymidine
incorporation assay 3 days later. Similar to human cells
stimulated with anti-CD3 and anti-CD28 antibodies, in vivo-
polarized 2D2 transgenic TH17 cells proliferated much more
vigorously and at lower concentrations of antigen compared with
TH2 cells expressing an identical TCR (Fig. 4b).
To be able to assess responses of primary human TH1, TH2 and
TH17 cells bearing an identical TCR speciﬁcity, we exploited
human T-cell plasticity, namely the ability of the cells to be at
least in part repolarized under speciﬁc in vitro culture
conditions26. T-cell clones were generated by limiting dilution
from CCR7þCCR6þCCR4þ memory T cells. At the time of
expansion, each clone was divided into three aliquots that were
cultured under either non-polarizing conditions (control) or in
the presence of IL-12 (‘TH1-like’ conditions) or IL-4 (‘TH2-like’
conditions; schematic in Fig. 4c). T-cell clones cultured under
non-polarizing conditions were mainly producing IL-17,
consistent with the notion that a high frequency of memory T
cells speciﬁc for C. albicans are TH17. Treatment of the same
clones with IL-4 and IL-12 had as a predominant effect the loss of
the TH17 phenotype (as determined by the reduction in IL-17
production) and, notably, a concomitant loss in miR-181a
expression (Fig. 4d,e). Culture of the same clones with IL-12 or
IL-4 led to a mild upregulation of IFNg and IL-4, respectively
(Supplementary Fig. 4), indicating loss of the TH17 phenotype
together with some degree of repolarization. Paired T-cell
clones were then compared for their capacity to proliferate in
response to increasing concentrations of C. albicans antigens
in the presence of autologous monocytes. T-cell clones cultured in
the presence of IL-12 or IL-4 showed overall reduced responses
compared with the same TH17 cells cultured in the absence of
repolarizing cytokines, especially in the presence of IL-4
(Fig. 4f,g). These data indicate that differences in proliferating
capacity are intrinsic to the phenotype of the responding T cells.
To further strengthen our data, we were able to isolate from the
blood of a healthy donor memory T-cell clones speciﬁc for
C. albicans and carrying identical Vb CDR3 TCR sequences, but
with different phenotypes (namely TH17 and TH2; ref. 27). On
restimulation of these clones with C. albicans lysates, TH17 cells
proliferated more vigorously compared with TH2 cells expressing
the same Vb TCR speciﬁcity (Supplementary Fig. 5a).
Importantly, the magnitude of proliferation closely correlated
with the levels of expression of miR-181a in each individual
clone, with the TH17 clone that displayed the strongest
proliferation also showing the highest expression of this miRNA
(Supplementary Fig. 5b).
On the whole, our data indicate that TH17 cells, independently
of TCR speciﬁcity, have an intrinsically lower threshold of
activation to cognate antigens compared with other subsets such
as TH2. Moreover, such threshold is at least in part regulated by
sustained ERK phosphorylation and miR-181a expression.
ID3 is induced upon activation in an ERK-dependent manner.
As mentioned above, TH17 clones showed sustained ERK phos-
phorylation for prolonged periods of time, as compared with TH2
clones (Supplementary Fig. 2). Speciﬁcally, by analysing a broad
panel of phosphorylated proteins, we found that at late time
points (day 5), the majority of signalling molecules did not show
any signiﬁcant change compared with baseline (day 0) in both
TH17 and TH2 cells, consistent with the notion that most of these
pathways have early and transient kinetics. However, we found
some sustained STAT protein phosphorylation, which was
somewhat expected on T-cell stimulation, as it was previously
shown that STAT3 and STAT5 contribute to regulate IL-17
production and RORC expression18,28–31. Most importantly, we
found that ERK1/2 remained phosphorylated in TH17 (but not in
TH2) cells at more than 4-fold over the baseline after 5 days from
the initial stimulation (Supplementary Fig. 2). Increased ERK
phosphorylation in activated TH17 clones compared with TH2
was also conﬁrmed by intracellular staining (Fig. 5a,b). Since
human memory TH17 cells transiently lose the ability to produce
IL-17 5 days after antigenic stimulation (Fig. 5c)18, and since ERK
phosphorylation was sustained in TH17 cells within the same time
frame, we assessed whether loss of cytokine production by TH17
cells was also dependent on ERK signalling. First, we established
working concentrations of a speciﬁc ERK inhibitor (ERKi) that
did not completely block TCR signalling, but still allowed T-cell
activation and proliferation as assessed by CFSE dilution
(Fig. 5d). TH17 clones were either left resting or stimulated
with anti-CD3 and anti-CD28 antibodies in the presence or
absence of increasing concentrations of ERKi. After 5 days, the
percentage of IL-17-producing cells was assessed by intracellular
staining. Although the majority of cells lost the ability to express
IL-17 after stimulation, cytokine production was almost
completely recovered with increasing concentrations of ERKi
(Fig. 5e). In these same experimental conditions, both IL17 and
RORC mRNA expression were almost completely recovered in
the presence of ERKi (Fig. 5f).
We previously showed that loss of IL17 transcription in
activated T cells was due, at least in part, to a loss in RORgt
expression18. Here we hypothesized that ERK-dependent
induction of a negative regulator of transcription may also have
a role in the loss of RORC mRNA expression. The region
upstream the RORC transcription start site was shown to contain
several binding sites for the bHLH protein E2A (ref. 32). ID3, a
negative regulator of bHLH protein activity, was shown to mildly
inﬂuence INFg expression33 and to counteract IL-17 production
and TH17 differentiation in the mouse34. Moreover, ID3
expression was also shown to depend on ERK activation in T
cells35. We therefore investigated the expression of ID3 upon
TCR stimulation. Interestingly, ID3 expression inversely
correlated with RORC and IL17 expression in activated TH17
cells, with a strong induction 5 days after initial stimulation
(Fig. 5f). ID3 induction was also dependent on ERK
phosphorylation, as assessed by activating cells in the presence
of ERKi (Fig. 5f). These data point towards a direct role for ID3 as
a negative regulator of RORC (and IL17) expression in recently
activated TH17.
ID3 inhibits RORC and IL17 expression. To investigate
expression and function of ID3 in this system, we stimulated
freshly isolated TH17 cells with plate-bound anti-CD3 and anti-
CD28, and assessed the expression of RORC and ID3 mRNA over
time (Fig. 6a). RORC expression showed a strong downregulation
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in the ﬁrst 6 days after stimulation, which was slowly recovered
over time and correlated with the transient downregulation of IL-
17 expression that we previously described (Fig. 5c). Vice versa,
ID3 expression showed an opposite trend, with increased
expression that slowly returned to low, baseline levels (Fig. 6a).
Similar results were obtained using antigen-speciﬁc TH17-cell
clones stimulated with Mycobacterium tuberculosis, which upon
restimulation showed increased ID3 expression and concomitant
loss of RORC and IL17 mRNA (Fig. 6b).
To address whether ID3 induction directly determined the
downregulation of RORC and IL17 expression, we transfected
TH17 cells sorted ex vivo from peripheral blood with an siRNA
against ID3 (siID3) (Fig. 6c). Cells were then stimulated with
anti-CD3 and anti-CD28 antibodies for 2 days before RNA
extraction and assessment of ID3, RORC and IL17 expression.
Upon siRNA-mediated knockdown of ID3 expression, stimulated
cells recovered both RORC and IL17 expression (Fig. 6c),
indicating that ID3 upregulation upon TCR engagement directly
led to the downregulation of RORC and IL17 transcription. To
further conﬁrm the role of ID3 in regulating RORC expression,
we transfected ex vivo-isolated resting TH17 cells with a plasmid
expressing ID3. Transfection efﬁciency was B70%, as indicated
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Figure 4 | Low threshold of TCR activation in TH17 cells. (a) Transgenic mouse 2D2 naive T cells were adoptively transferred into C57Bl/6 wild-type
recipients (105 cells per mouse) and polarized in vivo with MOG35–55 and either complete Freund’s adjuvant or alum as adjuvants. Six days after, challenge
cells were recovered from the draining lymph nodes and their polarization assessed by intracellular cytokine staining after restimulation with PMA and
ionomycin for 5 h. Data are representative of three independent experiments. (b) Cells as in a were recovered from the draining lymph nodes after adoptive
transfer and in vivo polarization, and were restimulated in vitro with bone marrow-derived dendritic cells matured overnight with lipopolysaccharide and
pulsed with increasing concentrations of MOG35–55 peptide. Cell proliferation was assessed after 3 days by
3H-thymidine incorporation assay. Fifteen mice
were pooled for the TH17 conditions (complete Freund’s adjuvant) and thirty for TH2 (alum). Representative of two independent experiments. (c)
Schematic representation of the experimental setup for panels d–g: C. albicans-speciﬁc central memory human TH17 cells were selected from the total pool
of TH17 cells, and individual cells were cloned and expanded. Each clone was divided into three aliquots that were cultured under either non-polarizing
conditions (control) or with addition of IL-12 or IL-4. (d) Percentage of IL-17-producing cells in individual clones was assessed by stimulation with PMA and
ionomycin and intracellular staining. Each dot represents one clone and subclones are connected by lines. (e) miR-181a expression was assessed in the
same ﬁve clones as in d. Shown are the compiled results for all the clones (mean±s.e.m.). P values were calculated by paired Student’s t-test, two-tailed.
(f) The same clones as in d were restimulated with increasing concentrations of C. albicans lysate in the presence of autologous monocytes. Three days
after stimulation, T-cell proliferation was assessed by 3H-thymidine incorporation assay. One representative clone is shown. (g) Overall proliferation of ﬁve
clones treated as in f and stimulated with 1.6 mgml 1 of C. albicans lysate (mean±s.e.m.). P values were calculated by paired Student’s t-test, two-tailed.
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by the GFP expressed from the same mRNA as ID3. Forty-eight
hours after transfection, cells were lysed for RNA extraction.
Compared with a GFP-only expression vector (pGFP), cells
transfected with the ID3-expressing plasmid (pID3) showed
strongly reduced RORC and IL17 expression (Fig. 6d), further
indicating that ID3 induction repressed these genes in activated
TH17 cells.
Sustained ERK phosphorylation in TH17 cells therefore
determines both the threshold of TH17 cell activation in response
to secondary encounters with an antigen, and ID3 induction,
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thereby leading to the transient loss of IL-17 production observed
in recently activated TH17 cells. Such reduction in cytokine
production may represent a cell-intrinsic mechanism aimed at
dampening inﬂammation and tissue damage.
Discussion
T-cell responses must be carefully regulated and resolved to avoid
collateral tissue damage and, in some cases, chronic pathology36.
It is now clear that a complex regulatory network comprising
both transcriptional and post-transcriptional components is
responsible for the differentiation, maintenance and function of
the different T-cell subsets9. Here, we showed that given the same
TCR speciﬁcity, the phenotype acquired by a T cell during the
primary response also inﬂuences the threshold of activation to a
subsequent encounter with the same antigen.
Given a similar cytokine environment, each naive T cell has an
intrinsic tendency to produce certain types of effector cells in part
because of the nature of its unique TCR37. Indeed, it is well
established that the strength of TCR stimulation determines the
capabilities of naive T cells to polarize to speciﬁc subsets6,7. Vice
versa, here we showed that the speciﬁc phenotype of a memory T
cell also determines the threshold of its response to a secondary
encounter with the same antigen. In other words, given the same
TCR speciﬁcity, memory TH17 cells will be able to respond to
lower concentrations of antigen with full-blown activation and
proliferation, as compared, for example, with memory TH2 cells.
Such lower threshold of activation in response to a speciﬁc
antigen may also partially account for the pathogenicity of TH17
cells in certain autoimmune diseases.
The molecular mechanism underlying the enhanced
responses in TH17 cells relies on the sustained ERK phosphor-
ylation observed in memory TH17 cells compared with other
subsets (Fig. 7). ERK phosphorylation is maintained by a self-
sustaining, feed-forward loop that includes miR-181a and leads
to the reduced expression of ERK-speciﬁc phosphatases.
Sustained ERK phosphorylation determines on one hand a
reduced activation threshold upon re-encounter of a memory
TH17 cell with its cognate antigen, and on the other a transient
downregulation of IL-17 production mediated by the induction
of the negative regulator ID3. Importantly, as we previously
showed18, a second pathway converges on the promoters
of the RORC and IL17 genes and negatively modulates their
expression: indeed, activated TH17 cells express CD25 (IL-2Ra),
thereby becoming responsive to IL-2. IL-2-activated STAT5
competes with phospho-STAT3 for the IL17 promoter and thus
negatively impacts on its activation30. During priming of naive T
cells, the initial cytokine signalling is responsible for the
establishment and/or maintenance of higher levels of miR-
181a expression speciﬁcally in TH17 cells, with IL-6, IL-1b and
TGFb (but not IL-4 or IL-12) being all able to induce, to various
extents, the expression of this miRNA.
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While a handful of miRNAs were already reported to regulate
TH17 cell differentiation38–41, our data showed that miR-181a
reduces the threshold of antigenic stimulation for the TCR
speciﬁcally in TH17 cells. Dysregulation of miR-181a in immature
T cells was already shown to impair both positive and negative
thymic selection11. Here, we showed that miR-181a has an
additional role in regulating TCR sensitivity also in the periphery
upon restimulation of memory TH17 cells. Such reduced
threshold of activation of TH17 cells compared with other
T-cell subsets may lead to increased responses to a speciﬁc
antigen. Of note, miR-181a was recently associated with the
susceptibility to develop EAE in rats, showing higher expression
in a strain susceptible to EAE compared with an EAE-resistant
one42, pointing towards a potential role for miR-181a in
regulating speciﬁc TH17-cell responses in autoimmunity.
The opposing actions of kinases and phosphatases enzymes in
the cell determine the level of phosphorylation of a given protein,
and the resulting effect of MAPK signalling depends on both the
magnitude and duration of kinase activation23. The
downregulation of phosphatases mediated by miR-181a is likely
to be especially critical for the maintenance of the signal over
time: indeed, it has been suggested that kinases collectively
control signal amplitude, while phosphatases regulate both
amplitude and duration43. Excessive activation of MAPK is also
associated with many autoimmune and inﬂammatory diseases44.
Highlighting an important link between TCR signalling and
autoimmunity, basal levels of ERK phosphorylation (but not of
p38) were shown to be signiﬁcantly increased in T cells from
patients with rheumatoid arthritis, possibly predisposing them to
activate autoreactive T cells45.
In summary, we have shown that given the same TCR
speciﬁcity, the phenotype acquired by a T cell during the primary
response also inﬂuences the threshold of activation to a
subsequent encounter with the same antigen. Speciﬁcally, TH17
cells appear to acquire increased sensitivity to lower concentra-
tions of antigen, with an underlying molecular mechanism that
involves sustained ERK phosphorylation mediated, at least in
part, by miR-181a. Moreover, sustained levels of ERK phosphor-
ylation also mediated other features of TH17 cells, including a
transient downmodulation of cytokine production consequence
of ID3 induction as well as IL-2 signalling. We speculate that
dysregulation of such network regulating TH17-cell activation and
IL-17 production may have important implications in the
development of autoimmune diseases.
Methods
Human T-cell isolation. Blood from healthy donors was obtained from the Swiss
Blood Donation Center of Basel and Lugano, with informed consent from the Swiss
Red Cross. Peripheral blood mononuclear cells were isolated using Ficoll-Paque Plus
(GE Healthcare), and CD14þ monocytes and CD4þ T cells were further isolated
by positive selection with CD14 and CD4-speciﬁc microbeads (Miltenyi Biotec).
Naive and memory T-cell subsets were isolated on the basis of the following
markers: CD45RAþCD45ROCCR7þCD95CD25CD8 (naive); CD45RA
CXCR3þCCR4CCR6CD25CD8 (enriched in TH1); CD45RACXCR3
CCR4þCCR6CD25CD8 (enriched in TH2); CD45RACXCR3CCR4þ
CCR6þCD25CD8 (enriched in TH17). In some experiments central memory
(TCM) TH17 cells were also used, and were separated as CD45RACCR7þ
CXCR3CCR4þCCR6þCD25CD8 . Cells were sorted with a FACSAria (BD
Biosciences). Where indicated, T-cell subsets were also separated by cytokine
secretion assay (Miltenyi Biotec) on the basis of their ability to produce signature
cytokines (INFg for TH1, IL-4 for TH2 and IL-17 for TH17 cells).
Cell culture and polarization. T cells were cultured in RPMI-1640 medium
supplemented with 2mM glutamine, 1% non-essential amino acids, 1% sodium
pyruvate, penicillin (50Uml 1), streptomycin (50 mgml 1) and 5% human serum
(Swiss Blood Center). For T-cell cloning, T cells were distributed at 0.5 cells per
well in 384-well plates in the presence of IL-2 (500Uml 1), 1 mgml 1 of phy-
tohaemagglutinin (PHA) as well as 25.000 irradiated (45Gy) allogeneic feeders
(peripheral blood mononuclear cells) per well as previously described26. The clones
were transferred after 2 weeks to round-bottom 96-well plates and expanded.
Antigen-speciﬁc T-cell clones were generated from memory T cells as previously
described18,26. Brieﬂy, memory T-cell subsets were labelled with CFSE according to
standard protocols; after 5 days of stimulation with antigen-pulsed monocytes (see
below), CFSE-negative cell populations were sorted and cloned by limiting dilution,
and stimulated with PHA, irradiated allogeneic feeder cells and IL-2. For some
clones, the TCR Vb sequences were obtained following ampliﬁcation with Vb-
speciﬁc primers, and clonotypes bearing identical receptor were identiﬁed among
different subsets (namely CCR6CCR4þ for TH2 and CCR6þCCR4þ for TH17).
T-cell stimulation. Memory T cells isolated ex vivo were stimulated with plate-
bound anti-CD3 (concentrations as indicated in ﬁgures, clone TR66) and anti-CD28
(1mgml 1, clone CD28.2) or antigen-pulsed monocytes. Autologous monocytes
were pre-incubated for 3 h with whole particles or lysates of C. albicans and irra-
diated (45Gy) before co-culture with T cells, as previously described18. Brieﬂy, C.
albicans conidia were killed by heating at 65 C for 1 h. Lysate was prepared through
repeated sonication cycles of C. albicans suspension (30 cycles, 45 s on, 90 s off on
ice), and sterile ﬁltered at 0.22mm. Protein concentration was determined by
Bradford reagent assay (Bio-Rad), and the optimal concentrations of inactivated
microorganisms to use in co-culture experiments were determined after titration in
proliferation assays using 3H-thymidine incorporation. T-cell proliferation was
measured 2–3 days after initial stimulation, upon addition of 1mCiml 1 3H-
thymidine (Perkin Elmer) for 16 h. In some experiments, T-cell clones speciﬁc for
M. tuberculosis were also used. M. tuberculosis whole-cell lysates were purchased
from BEI Resources and used at 5 mgml 1. Where indicated, CFSE-labelled
memory T cells were stimulated with plate-bound anti-CD3 and anti-CD28 in the
presence of increasing concentration of ERK inhibitor (MEK kinase inhibitor,
PD98059, Invivogen) and proliferation was measured by CFSE dilution.
Mouse colonies. All mice were bred and maintained under speciﬁc pathogen-free
conditions. C57Bl/6 mice were obtained from Harlan (Italy), while TCRMOG
2D2 mice were obtained from V. Kuchroo25. Female animals of 6–10 weeks
of age were used in all the experiments. The animals were treated in accordance
with guidelines of the Swiss Federal Veterinary Ofﬁce and experiments were
approved by the Dipartimento della Sanita`e Socialita` of Canton Ticino,
authorization number 09-2012.
Murine T-cell differentiation. For in vitro T-cell differentiation, sorted naive
CD4þCD25CD62L-high and CD44-low 2D2 cells25 were activated with plate-
bound anti-CD3 and anti-CD28 (2 mgml 1 each) in the presence of polarizing
cytokines and anti-cytokine antibodies as described46,47. Brieﬂy, the following
polarizing cytokines were added to the cultures: IL-12 (for TH1 conditions),
IL-4 (for TH2 conditions), IL-6 and TGFb (for TH17 conditions). In the non-
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Figure 7 | Modulation of memory TH17 cell responses by miR-181a and
ERK. Non-comprehensive representation of TCR and IL-2 signalling in
memory T cells, highlighting the novel ﬁndings of this study. ERK
phosphorylation is maintained in human memory TH17 cells by miR-181a,
which leads to the reduced expression of ERK-speciﬁc phosphatases. Initial
induction of miR-181a expression upon priming of naive Tcells is speciﬁcally
mediated by cytokines that favour TH17 polarization, such as IL-6, IL-1b and
TGFb. Sustained ERK phosphorylation not only regulates the activation
threshold upon TCR triggering in TH17 cells, but it also leads to a transient
downregulation of cytokine production mediated by induction of the
negative regulator ID3. A previous study showed that a second, IL-2/
STAT5-dependent pathway also converges on the promoters of the RORC/
IL17 genes to negatively modulate their expression (in grey in the ﬁgure)18.
IL-2 and TCR signalling also lead to the activation of other pathways in
addition to the ones shown in this schematic graph.
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polarizing ‘Th0’ condition, no cytokines were added to the culture. For in vivo
T-cell polarization, 105 naive 2D2 cells T cells (CD90.1) were injected in the tail
vein of C57Bl/6 mice. The following day, mice were immunized subcutaneously
with 150 mg of myelin oligodendrocyte glycoprotein peptide fragment 35–55
(MOG35–55) in the presence of two different adjuvants, complete Freund’s adjuvant
(with 4mgml 1 of M. tuberculosis H37RA, Difco) or Imject Alum (Pierce
Biotechnology). After 6 days, 2D2 cells were recovered from the draining lymph
nodes and were restimulated in vitro with bone marrow-derived dendritic cells
(matured overnight with 0.5 mgml 1 of ultrapure Escherichia coli O111-BA LPS,
Invivogen) pulsed with increasing concentration of MOG35–55 peptide. Bone
marrow-derived dendritic cells were generated according to a standard protocol48
using the supernatant of a GM-CSF producing cell line49,50. Cell proliferation was
assessed after 3 days by 3H-thymidine incorporation assay.
RNAi and miRNA transfection. For miRNA overexpression and functional
ablation, speciﬁc oligonucleotides (miR-181a mimic, antagomir and negative
scrambled controls) were purchased from ThermoScientiﬁc and Exiqon. For RNAi-
mediated knockdown of ID3, a previously described siRNA against human ID3
(ref. 51) was used (ThermoScientiﬁc, Dharmacon). For transfection of miRNAs or
siRNAs, 1–2 106 memory T-cell subsets were transfected with 200 pmol oligo-
nucleotides or controls, using Amaxa Nucleofector reagent (Lonza) and Amaxa
electroporator with program U-14 following manufacturer’s instructions. In pre-
liminary experiments, efﬁciency of transfection was assessed using a ﬂuorescent
oligonucleotide (siGLO, ThermoScientiﬁc). After 48 h from transfection, T cells
were stimulated with plate-bound anti-CD3 and anti-CD28 or antigen-pulsed
monocytes. The proliferation rate was measured after 3 days on addition of
1mCiml 1 3H-thymidine for 16 h.
Plasmids. The full-length cDNA for human ID3 was purchased from OriGene and
subcloned into a mammalian expression vector using common cloning techniques.
Memory T-cell subsets (1–2 106) were transfected with 1 mg of plasmid using
Amaxa (program U-14).
Intracellular staining. To assess cytokine production, cells were stimulated for 5 h
with PMA (200 nM) and ionomycin (1mgml 1) in the presence of 10mgml 1
brefeldin A (all from Sigma-Aldrich) for the ﬁnal 2.5 h of culture before ﬁxation
and permeabilization with Cytoﬁx/Cytoperm (BD Biosciences), according to
manufacturer’s instructions. Cells were then stained with anti-IL-17, anti-IFNg and
anti-IL-4 antibodies conjugated to different ﬂuorochromes, and were acquired on a
FACSCanto (BD Bioscience). Flow cytometry data were analysed with FlowJo
(Tree Star). For intracellular detection of phosphorylated ERK (pERK), cells were
stimulated with plate-bound anti-CD3 and anti-CD28 for the indicated times, prior
ﬁxation with 3.7% formaldehyde and permeabilization with 90% methanol.
Staining was performed with a 1:200 dilution of a phospho-speciﬁc-p44/42 MAPK
(Erk1/2) (Thr202/Tyr204) (Cell Signaling; cat no. 4377S).
RNA extraction and quantitative PCR with reverse transcription (qRT–PCR).
Total RNA was extracted using TRIzol reagent (Invitrogen) according to manu-
facturer’s instructions. Random hexamer primers and a reverse transcriptase kit
(Stratagene) were used for cDNA synthesis. Transcripts were quantiﬁed by qRT–
PCR on an ABI PRISM 7900HT with predesigned TaqMan Gene Expression
Assays and reagents (Applied Biosystems). TaqMan assays were as follows: IL17A
(Hs99999082), RORC (Hs01076122_m1), ID3 (Hs00171409_m1), DUSP5
(Hs00244839_m1), PTPN11 (Hs00743983_s1), DUSP6 (Hs04329643_s1). To ana-
lyse miRNA expression levels, qRT–PCR was performed using a miRNA reverse
transcription kit and TaqMan miRNA assays from Applied Biosystems, following
manufacturer’s instructions. Expression of target genes and miRNAs were nor-
malized to 18S ribosomal RNA and RNU48, respectively. For data analysis, the
DDCt method was used52. TCR Vb analysis and sequencing were performed
exactly as described24,27.
Statistical analysis. Statistical analysis was performed with the Prism software
(GraphPad). Data are represented as mean±s.e.m. or s.d., and signiﬁcance was
assessed by paired or unpaired Student’s t-test, two-tailed.
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